UMB Bank n.a. Reduces Position in The Procter & Gamble Company (NYSE:PG)

UMB Bank n.a. lessened its holdings in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 2.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 326,443 shares of the company’s stock after selling 8,070 shares during the period. UMB Bank n.a.’s holdings in Procter & Gamble were worth $47,837,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Dfpg Investments LLC boosted its holdings in shares of Procter & Gamble by 1.7% in the fourth quarter. Dfpg Investments LLC now owns 24,892 shares of the company’s stock valued at $3,680,000 after purchasing an additional 424 shares during the period. Garrett Wealth Advisory Group LLC lifted its holdings in Procter & Gamble by 6.3% during the third quarter. Garrett Wealth Advisory Group LLC now owns 4,419 shares of the company’s stock worth $645,000 after buying an additional 260 shares during the period. N.E.W. Advisory Services LLC lifted its holdings in Procter & Gamble by 14.6% during the third quarter. N.E.W. Advisory Services LLC now owns 94,424 shares of the company’s stock worth $13,772,000 after buying an additional 12,016 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in Procter & Gamble by 0.8% during the third quarter. Charles Schwab Investment Management Inc. now owns 16,003,260 shares of the company’s stock worth $2,298,184,000 after buying an additional 131,339 shares during the period. Finally, Royal Bank of Canada lifted its holdings in Procter & Gamble by 26.9% during the second quarter. Royal Bank of Canada now owns 10,823,380 shares of the company’s stock worth $1,642,339,000 after buying an additional 2,293,824 shares during the period. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Insider Buying and Selling

In other Procter & Gamble news, CEO Gary A. Coombe sold 22,000 shares of Procter & Gamble stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $161.32, for a total value of $3,549,040.00. Following the transaction, the chief executive officer now directly owns 36,845 shares in the company, valued at $5,943,835.40. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, CEO Ma. Fatima Francisco sold 74,443 shares of the business’s stock in a transaction dated Wednesday, January 24th. The shares were sold at an average price of $153.30, for a total transaction of $11,412,111.90. Following the transaction, the chief executive officer now directly owns 973 shares in the company, valued at $149,160.90. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Gary A. Coombe sold 22,000 shares of the business’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the transaction, the chief executive officer now owns 36,845 shares in the company, valued at $5,943,835.40. The disclosure for this sale can be found here. Insiders have sold 279,063 shares of company stock worth $43,187,745 in the last ninety days. 0.17% of the stock is owned by corporate insiders.

Procter & Gamble Price Performance

Procter & Gamble stock opened at $156.16 on Thursday. The company has a fifty day simple moving average of $159.46 and a 200-day simple moving average of $152.40. The Procter & Gamble Company has a 12-month low of $141.45 and a 12-month high of $163.14. The company has a current ratio of 0.64, a quick ratio of 0.44 and a debt-to-equity ratio of 0.48. The stock has a market cap of $367.45 billion, a P/E ratio of 26.16, a price-to-earnings-growth ratio of 3.28 and a beta of 0.44.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings results on Tuesday, January 23rd. The company reported $1.84 EPS for the quarter, topping the consensus estimate of $1.70 by $0.14. Procter & Gamble had a net margin of 17.60% and a return on equity of 34.04%. The firm had revenue of $21.44 billion for the quarter, compared to analyst estimates of $21.48 billion. During the same period last year, the business earned $1.59 EPS. Procter & Gamble’s revenue for the quarter was up 3.2% compared to the same quarter last year. Equities analysts expect that The Procter & Gamble Company will post 6.45 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, February 15th. Investors of record on Friday, January 19th were paid a dividend of $0.9407 per share. The ex-dividend date of this dividend was Thursday, January 18th. This represents a $3.76 annualized dividend and a yield of 2.41%. Procter & Gamble’s dividend payout ratio is currently 62.98%.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on PG shares. JPMorgan Chase & Co. lowered their target price on Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating for the company in a report on Thursday, January 18th. Royal Bank of Canada upped their price target on Procter & Gamble from $156.00 to $157.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 24th. Barclays upped their target price on Procter & Gamble from $160.00 to $165.00 and gave the company an “overweight” rating in a research report on Thursday, January 25th. Raymond James upped their price target on shares of Procter & Gamble from $170.00 to $175.00 and gave the company an “outperform” rating in a report on Wednesday, January 24th. Finally, Stifel Nicolaus upped their price target on shares of Procter & Gamble from $155.00 to $157.00 and gave the company a “hold” rating in a report on Wednesday, January 24th. Seven investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average target price of $168.35.

View Our Latest Stock Report on PG

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.